Filed: 11/14/2022ACC: 0000950123-22-011712
📋 What this filing means
ABG INNOVATION CAPITAL PARTNERS III GP LTD filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $1.5K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$1.5K
Total AUM (reported)
697.45K
Total Shares
Allocation by class
COM$1.4K98.3%
COM PAR$21.001.4%
COM NEW$4.000.3%
Portfolio Concentration
Top 3$1.4K98.3%
4–10$25.001.7%
Top 3 weight
98.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 697.45K
Sole
Full voting authority
697.45K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other5
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
CASTLE BIOSCIENCES INC
DFNDShares33.63K
TypeSH
Market value$877.00
59.46%
Sole
33.63K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
DFNDShares26.67K
TypeSH
Market value$377.00
25.56%
Sole
26.67K
Shared
0.00
None
0.00
SYNLOGIC INC
DFNDShares205.91K
TypeSH
Market value$196.00
13.29%
Sole
205.91K
Shared
0.00
None
0.00
IDERA PHARMACEUTICALS INC
DFNDShares56.25K
TypeSH
Market value$21.00
1.42%
Sole
56.25K
Shared
0.00
None
0.00
GENOCEA BIOSCIENCES INC
DFNDShares375K
TypeSH
Market value$4.00
0.27%
Sole
375K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CASTLE BIOSCIENCES INCDFND | COM | 33.63K | SH | $877.00 59.46% | 33.63K | 0.00 | 0.00 |
AADI BIOSCIENCES INCDFND | COM | 26.67K | SH | $377.00 25.56% | 26.67K | 0.00 | 0.00 |
SYNLOGIC INCDFND | COM | 205.91K | SH | $196.00 13.29% | 205.91K | 0.00 | 0.00 |
IDERA PHARMACEUTICALS INCDFND | COM PAR | 56.25K | SH | $21.00 1.42% | 56.25K | 0.00 | 0.00 |
GENOCEA BIOSCIENCES INCDFND | COM NEW | 375K | SH | $4.00 0.27% | 375K | 0.00 | 0.00 |